{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T01:51:54Z","timestamp":1793497914718,"version":"4.5.0"},"reference-count":129,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T00:00:00Z","timestamp":1693872000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T00:00:00Z","timestamp":1693872000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001867","name":"Malta Council for Science and Technology","doi-asserted-by":"publisher","award":["R&I-2019-018T"],"award-info":[{"award-number":["R&I-2019-018T"]}],"id":[{"id":"10.13039\/501100001867","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001867","name":"Malta Council for Science and Technology","doi-asserted-by":"publisher","award":["R&I-2022-007L"],"award-info":[{"award-number":["R&I-2022-007L"]}],"id":[{"id":"10.13039\/501100001867","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100006306","name":"Sigrid Jus\u00e9liuksen S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006306","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015736","name":"Folkh\u00e4lsan Research Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100015736","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Stockholm County Council"},{"DOI":"10.13039\/501100006129","name":"Konung Gustaf V:s och Drottning Victorias Frimurarestiftelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006129","id-type":"DOI","asserted-by":"publisher"}]},{"name":"University of Helsinki including Helsinki University Central Hospital"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Osteoporosis is a metabolic bone disorder which increases fragility fracture risk. Elderly individuals, especially postmenopausal women, are particularly susceptible to osteoporosis. Although rare, osteoporosis in children and young adults is becoming increasingly evident, highlighting the need for timely diagnosis, management and follow-up. Early-onset osteoporosis is defined as the presence of a low BMD (Z-score of\u2009\u2264\u2009\u22122.0 in individuals aged\u2009&lt;\u200920\u00a0years; T-score of\u2009\u2264\u2009\u22122.5 in those aged between 20 to 50\u00a0years) accompanied by a clinically significant fracture history, or the presence of low-energy vertebral compression fractures even in the absence of osteoporosis. Affected children and young adults should undergo a thorough diagnostic workup, including collection of clinical history, radiography, biochemical investigation and possibly bone biopsy. Once secondary factors and comorbidities are excluded, genetic testing should be considered to determine the possibility of an underlying monogenic cause. Defects in genes related to type I collagen biosynthesis are the commonest contributors of primary osteoporosis, followed by loss-of-function variants in genes encoding key regulatory proteins of canonical WNT signalling (specifically\n                    <jats:italic>LRP5<\/jats:italic>\n                    and\n                    <jats:italic>WNT1<\/jats:italic>\n                    ), the actin-binding plastin-3 protein (encoded by\n                    <jats:italic>PLS3<\/jats:italic>\n                    ) resulting in X-linked osteoporosis, and the more recent sphingomyelin synthase 2 (encoded by\n                    <jats:italic>SGMS2<\/jats:italic>\n                    ) which is critical for signal transduction affecting sphingomyelin metabolism. Despite these discoveries, genetic causes and underlying mechanisms in early-onset osteoporosis remain largely unknown, and if no causal gene is identified, early-onset osteoporosis is deemed idiopathic. This calls for further research to unravel the molecular mechanisms driving early-onset osteoporosis that consequently will aid in patient management and individualised targeted therapy.\n                  <\/jats:p>","DOI":"10.1007\/s40618-023-02179-0","type":"journal-article","created":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T10:02:52Z","timestamp":1693908172000},"page":"285-298","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":57,"title":["Bone fragility and osteoporosis in children and young adults"],"prefix":"10.1007","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7852-2701","authenticated-orcid":false,"given":"M. M.","family":"Formosa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0398-0051","authenticated-orcid":false,"given":"M. A.","family":"Christou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4547-001X","authenticated-orcid":false,"given":"O.","family":"M\u00e4kitie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,5]]},"reference":[{"key":"2179_CR1","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/s0140-6736(18)32112-3","volume":"393","author":"JE Compston","year":"2019","unstructured":"Compston JE, McClung MR, Leslie WD (2019) Osteoporosis Lancet 393:364\u2013376. https:\/\/doi.org\/10.1016\/s0140-6736(18)32112-3","journal-title":"Osteoporosis Lancet"},{"key":"2179_CR2","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1210\/er.2009-0044","volume":"31","author":"SH Ralston","year":"2010","unstructured":"Ralston SH, Uitterlinden AG (2010) Genetics of Osteoporosis. Endocr Rev 31:629\u2013662. https:\/\/doi.org\/10.1210\/er.2009-0044","journal-title":"Endocr Rev"},{"key":"2179_CR3","unstructured":"Cooper C and Ferrari S. IOF Compendium of Osteoporosis. 2nd edition ed2019. p. 1\u201390."},{"key":"2179_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2009.260","author":"N Harvey","year":"2010","unstructured":"Harvey N, Dennison E, Cooper C (2010) Osteoporosis: impact on health and economics. Nat Rev Rheumatol. https:\/\/doi.org\/10.1038\/nrrheum.2009.260","journal-title":"Nat Rev Rheumatol"},{"key":"2179_CR5","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1007\/s00198-017-3921-7","volume":"28","author":"E Lespessailles","year":"2017","unstructured":"Lespessailles E, Cortet B, Legrand E, Guggenbuhl P, Roux C (2017) Low-trauma fractures without osteoporosis. Osteoporos Int 28:1771\u20131778. https:\/\/doi.org\/10.1007\/s00198-017-3921-7","journal-title":"Osteoporos Int"},{"key":"2179_CR6","doi-asserted-by":"publisher","first-page":"e239","DOI":"10.1016\/s2468-2667(17)30046-4","volume":"2","author":"N Papadimitriou","year":"2017","unstructured":"Papadimitriou N, Tsilidis KK, Orfanos P, Benetou V, Ntzani EE, Soerjomataram I, K\u00fcnn-Nelen A, Pettersson-Kymmer U, Eriksson S, Brenner H et al (2017) Burden of hip fracture using disability-adjusted life-years: a pooled analysis of prospective cohorts in the CHANCES consortium Lancet. Public Health 2:e239\u2013e246. https:\/\/doi.org\/10.1016\/s2468-2667(17)30046-4","journal-title":"Public Health"},{"key":"2179_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2013.45","author":"O M\u00e4kitie","year":"2013","unstructured":"M\u00e4kitie O (2013) Causes, mechanisms and management of paediatric osteoporosis. Nat Rev Rheumatol. https:\/\/doi.org\/10.1038\/nrrheum.2013.45","journal-title":"Nat Rev Rheumatol"},{"key":"2179_CR8","doi-asserted-by":"publisher","first-page":"70","DOI":"10.3389\/fendo.2019.00070","volume":"10","author":"RE M\u00e4kitie","year":"2019","unstructured":"M\u00e4kitie RE, Costantini A, K\u00e4mpe A, Alm JJ, M\u00e4kitie O (2019) New insights into monogenic causes of osteoporosis. Front Endocrinol (Lausanne) 10:70. https:\/\/doi.org\/10.3389\/fendo.2019.00070","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2179_CR9","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/421746","author":"R Florencio-Silva","year":"2015","unstructured":"Florencio-Silva R, Sasso GR, Sasso-Cerri E, Sim\u00f5es MJ, Cerri PS (2015) Biology of bone tissue: structure function and factors that influence bone cells. Biomed Res Int. https:\/\/doi.org\/10.1155\/2015\/421746","journal-title":"Biomed Res Int"},{"issue":"Suppl 3","key":"2179_CR10","doi-asserted-by":"publisher","first-page":"S131","DOI":"10.2215\/cjn.04151206","volume":"3","author":"B Clarke","year":"2008","unstructured":"Clarke B (2008) Normal bone anatomy and physiology. Clin J Am Soc Nephrol 3(Suppl 3):S131-139. https:\/\/doi.org\/10.2215\/cjn.04151206","journal-title":"Clin J Am Soc Nephrol"},{"key":"2179_CR11","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1196\/annals.1365.035","volume":"1092","author":"DJ Hadjidakis","year":"2006","unstructured":"Hadjidakis DJ, Androulakis II (2006) Bone remodeling. Ann N Y Acad Sci 1092:385\u2013396. https:\/\/doi.org\/10.1196\/annals.1365.035","journal-title":"Ann N Y Acad Sci"},{"key":"2179_CR12","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1159\/000489672","volume":"47","author":"SM Ott","year":"2018","unstructured":"Ott SM (2018) Cortical or trabecular bone: what\u2019s the difference? Am J Nephrol 47:373\u2013375. https:\/\/doi.org\/10.1159\/000489672","journal-title":"Am J Nephrol"},{"key":"2179_CR13","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1177\/1759720x16670154","volume":"8","author":"B Langdahl","year":"2016","unstructured":"Langdahl B, Ferrari S, Dempster DW (2016) Bone modeling and remodeling: potential as therapeutic targets for the treatment of osteoporosis. Ther Adv Musculoskelet Dis 8:225\u2013235. https:\/\/doi.org\/10.1177\/1759720x16670154","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"2179_CR14","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1002\/jbmr.2152","volume":"29","author":"MS Ominsky","year":"2014","unstructured":"Ominsky MS, Niu QT, Li C, Li X, Ke HZ (2014) Tissue-level mechanisms responsible for the increase in bone formation and bone volume by sclerostin antibody. J Bone Miner Res 29:1424\u20131430. https:\/\/doi.org\/10.1002\/jbmr.2152","journal-title":"J Bone Miner Res"},{"key":"2179_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2015.89","author":"JN Farr","year":"2015","unstructured":"Farr JN, Khosla S (2015) Skeletal changes through the lifespan\u2013from growth to senescence. Nat Rev Endocrinol. https:\/\/doi.org\/10.1038\/nrendo.2015.89","journal-title":"Nat Rev Endocrinol"},{"key":"2179_CR16","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1002\/jbmr.5650090802","volume":"9","author":"JA Kanis","year":"1994","unstructured":"Kanis JA, Melton LJ 3rd, Christiansen C, Johnston CC, Khaltaev N (1994) The diagnosis of osteoporosis. J Bone Miner Res 9:1137\u20131141. https:\/\/doi.org\/10.1002\/jbmr.5650090802","journal-title":"J Bone Miner Res"},{"key":"2179_CR17","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1007\/s00223-021-00885-6","volume":"110","author":"O M\u00e4kitie","year":"2022","unstructured":"M\u00e4kitie O, Zillikens MC (2022) Early-onset osteoporosis. Calcif Tissue Int 110:546\u2013561. https:\/\/doi.org\/10.1007\/s00223-021-00885-6","journal-title":"Calcif Tissue Int"},{"key":"2179_CR18","doi-asserted-by":"publisher","first-page":"e2088","DOI":"10.1210\/clinem\/dgz294","volume":"105","author":"LM Ward","year":"2020","unstructured":"Ward LM, Weber DR, Munns CF, H\u00f6gler W, Zemel BS (2020) A contemporary view of the definition and diagnosis of osteoporosis in children and adolescents. J Clin Endocrinol Metab 105:e2088-2097. https:\/\/doi.org\/10.1210\/clinem\/dgz294","journal-title":"J Clin Endocrinol Metab"},{"key":"2179_CR19","doi-asserted-by":"publisher","first-page":"769","DOI":"10.3238\/arztebl.2018.0769","volume":"115","author":"O Berthold","year":"2018","unstructured":"Berthold O, Frericks B, John T, Clemens V, Fegert JM, Moers AV (2018) Abuse as a cause of childhood fractures. Dtsch Arztebl Int 115:769\u2013775. https:\/\/doi.org\/10.3238\/arztebl.2018.0769","journal-title":"Dtsch Arztebl Int"},{"key":"2179_CR20","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12969-020-0411-9","volume":"18","author":"R Galindo-Zavala","year":"2020","unstructured":"Galindo-Zavala R, Bou-Torrent R, Magallares-L\u00f3pez B, Mir-Perell\u00f3 C, Palmou-Fontana N, Sevilla-P\u00e9rez B, Medrano-San Ildefonso M, Gonz\u00e1lez-Fern\u00e1ndez MI, Rom\u00e1n-Pascual A, Alca\u00f1iz-Rodr\u00edguez P et al (2020) Expert panel consensus recommendations for diagnosis and treatment of secondary osteoporosis in children. Pediatr Rheumatol Online J 18:20. https:\/\/doi.org\/10.1186\/s12969-020-0411-9","journal-title":"Pediatr Rheumatol Online J"},{"key":"2179_CR21","doi-asserted-by":"publisher","DOI":"10.1080\/17453674.2020.1772555","author":"AV Larsen","year":"2020","unstructured":"Larsen AV, Mundbjerg E (2020) Lauritsen JM and Faergemann C (2020) Development of the annual incidence rate of fracture in children 1980\u20132018: a population-based study of 32375 fractures. Acta Orthop. https:\/\/doi.org\/10.1080\/17453674.2020.1772555","journal-title":"Acta Orthop"},{"key":"2179_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22020625","author":"A El-Gazzar","year":"2021","unstructured":"El-Gazzar A, H\u00f6gler W (2021) Mechanisms of bone fragility: from osteogenesis imperfecta to secondary osteoporosis. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms22020625","journal-title":"Int J Mol Sci"},{"key":"2179_CR23","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.jocd.2014.01.004","volume":"17","author":"N Bishop","year":"2013","unstructured":"Bishop N, Arundel P, Clark E, Dimitri P, Farr J, Jones G, Makitie O (2013) Munns CF and Shaw N (2014) Fracture prediction and the definition of osteoporosis in children and adolescents: the ISCD. Pediatric Official Positions J Clin Densitom 17:275\u2013280. https:\/\/doi.org\/10.1016\/j.jocd.2014.01.004","journal-title":"Pediatric Official Positions J Clin Densitom"},{"key":"2179_CR24","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.jocd.2014.01.007","volume":"17","author":"CM Gordon","year":"2014","unstructured":"Gordon CM, Leonard MB, Zemel BS (2014) 2013 Pediatric Position Development Conference: executive summary and reflections. J Clin Densitom 17:219\u2013224. https:\/\/doi.org\/10.1016\/j.jocd.2014.01.007","journal-title":"J Clin Densitom"},{"key":"2179_CR25","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.ecl.2016.09.007","volume":"46","author":"A Cohen","year":"2017","unstructured":"Cohen A (2017) Premenopausal osteoporosis endocrinol metab. Clin North Am 46:117\u2013133. https:\/\/doi.org\/10.1016\/j.ecl.2016.09.007","journal-title":"Clin North Am"},{"key":"2179_CR26","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/j.bone.2008.08.106","volume":"43","author":"EM Lewiecki","year":"2007","unstructured":"Lewiecki EM, Gordon CM, Baim S, Leonard MB, Bishop NJ, Bianchi ML, Kalkwarf HJ, Langman CB, Plotkin H, Rauch F et al (2007) (2008) International society for clinical densitometry. Adult and Pediatric Official Positions Bone 43:1115\u20131121. https:\/\/doi.org\/10.1016\/j.bone.2008.08.106","journal-title":"Adult and Pediatric Official Positions Bone"},{"key":"2179_CR27","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-012-2030-x","author":"S Ferrari","year":"2012","unstructured":"Ferrari S, Bianchi ML, Eisman JA, Foldes AJ, Adami S, Wahl DA, Stepan JJ, de Vernejoul MC, Kaufman JM (2012) Osteoporosis in young adults: pathophysiology diagnosis, and management. Osteoporos Int. https:\/\/doi.org\/10.1007\/s00198-012-2030-x","journal-title":"Osteoporos Int"},{"key":"2179_CR28","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.95","author":"C Berger","year":"2010","unstructured":"Berger C, Goltzman D, Langsetmo L, Joseph L, Jackson S, Kreiger N, Tenenhouse A, Davison KS, Josse RG, Prior JC et al (2010) Peak bone mass from longitudinal data: implications for the prevalence, pathophysiology, and diagnosis of osteoporosis. J Bone Miner Res. https:\/\/doi.org\/10.1002\/jbmr.95","journal-title":"J Bone Miner Res"},{"key":"2179_CR29","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/s0889-8529(02)00058-0","volume":"32","author":"S Mora","year":"2003","unstructured":"Mora S, Gilsanz V (2003) Establishment of peak bone mass. Endocrinol Metab Clin North Am 32:39\u201363. https:\/\/doi.org\/10.1016\/s0889-8529(02)00058-0","journal-title":"Endocrinol Metab Clin North Am"},{"key":"2179_CR30","doi-asserted-by":"publisher","first-page":"4702","DOI":"10.1210\/jcem.84.12.6182","volume":"84","author":"LK Bachrach","year":"1999","unstructured":"Bachrach LK, Hastie T, Wang MC, Narasimhan B, Marcus R (1999) Bone mineral acquisition in healthy Asian, Hispanic, black, and Caucasian youth: a longitudinal study. J Clin Endocrinol Metab 84:4702\u20134712. https:\/\/doi.org\/10.1210\/jcem.84.12.6182","journal-title":"J Clin Endocrinol Metab"},{"key":"2179_CR31","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.412","author":"AD Baxter-Jones","year":"2011","unstructured":"Baxter-Jones AD, Faulkner RA, Forwood MR, Mirwald RL, Bailey DA (2011) Bone mineral accrual from 8 to 30 years of age: an estimation of peak bone mass. J Bone Miner Res. https:\/\/doi.org\/10.1002\/jbmr.412","journal-title":"J Bone Miner Res"},{"key":"2179_CR32","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.75.4.1400871","author":"G Theintz","year":"1992","unstructured":"Theintz G, Buchs B, Rizzoli R, Slosman D, Clavien H, Sizonenko PC, Bonjour JP (1992) Longitudinal monitoring of bone mass accumulation in healthy adolescents: evidence for a marked reduction after 16 years of age at the levels of lumbar spine and femoral neck in female subjects. J Clin Endocrinol Metab. https:\/\/doi.org\/10.1210\/jcem.75.4.1400871","journal-title":"J Clin Endocrinol Metab"},{"key":"2179_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2022.101616","author":"T Chevalley","year":"2022","unstructured":"Chevalley T, Rizzoli R (2022) Acquisition of peak bone mass. Best Pract Res Clin Endocrinol Metab. https:\/\/doi.org\/10.1016\/j.beem.2022.101616","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"2179_CR34","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1002\/jbmr.4668","volume":"37","author":"A Costantini","year":"2022","unstructured":"Costantini A, M\u00e4kitie RE, Hartmann MA, Fratzl-Zelman N, Zillikens MC, Kornak U, S\u00f8e K, M\u00e4kitie O (2022) Early-onset osteoporosis: rare monogenic forms elucidate the complexity of disease pathogenesis beyond Type I collagen. J Bone Miner Res 37:1623\u20131641. https:\/\/doi.org\/10.1002\/jbmr.4668","journal-title":"J Bone Miner Res"},{"key":"2179_CR35","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.1007\/s00431-022-04455-2","volume":"181","author":"S Ciancia","year":"2022","unstructured":"Ciancia S, van Rijn RR, H\u00f6gler W, Appelman-Dijkstra NM, Boot AM, Sas TCJ, Renes JS (2022) Osteoporosis in children and adolescents: when to suspect and how to diagnose it. Eur J Pediatr 181:2549\u20132561. https:\/\/doi.org\/10.1007\/s00431-022-04455-2","journal-title":"Eur J Pediatr"},{"key":"2179_CR36","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1002\/art.40137","volume":"69","author":"L Buckley","year":"2017","unstructured":"Buckley L, Guyatt G, Fink HA, Cannon M, Grossman J, Hansen KE, Humphrey MB, Lane NE, Magrey M, Miller M et al (2017) 2017 American college of rheumatology guideline for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Rheumatol 69:1521\u20131537. https:\/\/doi.org\/10.1002\/art.40137","journal-title":"Arthritis Rheumatol"},{"key":"2179_CR37","doi-asserted-by":"publisher","first-page":"2547","DOI":"10.1056\/NEJMcp1800214","volume":"379","author":"L Buckley","year":"2018","unstructured":"Buckley L, Humphrey MB (2018) Glucocorticoid-induced osteoporosis. N Engl J Med 379:2547\u20132556. https:\/\/doi.org\/10.1056\/NEJMcp1800214","journal-title":"N Engl J Med"},{"key":"2179_CR38","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1097\/GRF.0b013e3182a8ae55","volume":"56","author":"A Abraham","year":"2013","unstructured":"Abraham A, Cohen A, Shane E (2013) Premenopausal bone health: osteoporosis in premenopausal women. Clin Obstet Gynecol 56:722\u2013729. https:\/\/doi.org\/10.1097\/GRF.0b013e3182a8ae55","journal-title":"Clin Obstet Gynecol"},{"key":"2179_CR39","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa306","author":"J Pepe","year":"2020","unstructured":"Pepe J, Body JJ, Hadji P, McCloskey E, Meier C, Obermayer-Pietsch B, Palermo A, Tsourdi E, Zillikens MC, Langdahl B et al (2020) Osteoporosis in premenopausal women a clinical narrative review by the ECTS and the IOF. J Clin Endocrinol Metab. https:\/\/doi.org\/10.1210\/clinem\/dgaa306","journal-title":"J Clin Endocrinol Metab"},{"key":"2179_CR40","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.2000.15.3.557","author":"AJ Black","year":"2000","unstructured":"Black AJ, Topping J, Durham B, Farquharson RG, Fraser WD (2000) A detailed assessment of alterations in bone turnover calcium homeostasis and bone density in normal pregnancy. J Bone Miner Res. https:\/\/doi.org\/10.1359\/jbmr.2000.15.3.557","journal-title":"J Bone Miner Res"},{"key":"2179_CR41","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/s8756-3282(03)00017-6","volume":"32","author":"M Kaur","year":"2003","unstructured":"Kaur M, Pearson D, Godber I, Lawson N, Baker P, Hosking D (2003) Longitudinal changes in bone mineral density during normal pregnancy. Bone 32:449\u2013454. https:\/\/doi.org\/10.1016\/s8756-3282(03)00017-6","journal-title":"Bone"},{"key":"2179_CR42","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1359\/jbmr.2000.15.1.129","volume":"15","author":"KE Naylor","year":"2000","unstructured":"Naylor KE, Iqbal P, Fledelius C, Fraser RB, Eastell R (2000) The effect of pregnancy on bone density and bone turnover. J Bone Miner Res 15:129\u2013137. https:\/\/doi.org\/10.1359\/jbmr.2000.15.1.129","journal-title":"J Bone Miner Res"},{"key":"2179_CR43","first-page":"841","volume":"77","author":"M Sowers","year":"1991","unstructured":"Sowers M, Crutchfield M, Jannausch M, Updike S, Corton G (1991) A prospective evaluation of bone mineral change in pregnancy. Obstet Gynecol 77:841\u2013845","journal-title":"Obstet Gynecol"},{"key":"2179_CR44","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-002-1320-0","author":"D Holmberg-Marttila","year":"2003","unstructured":"Holmberg-Marttila D, Leino A, Siev\u00e4nen H (2003) Bone turnover markers during lactation, postpartum amenorrhea and resumption of menses. Osteoporos Int. https:\/\/doi.org\/10.1007\/s00198-002-1320-0","journal-title":"Osteoporos Int"},{"key":"2179_CR45","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1080\/00016470510030274","volume":"76","author":"MK Karlsson","year":"2005","unstructured":"Karlsson MK, Ahlborg HG, Karlsson C (2005) Maternity and bone mineral density. Acta Orthop 76:2\u201313. https:\/\/doi.org\/10.1080\/00016470510030274","journal-title":"Acta Orthop"},{"key":"2179_CR46","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1056\/nejm199708213370803","volume":"337","author":"HJ Kalkwarf","year":"1997","unstructured":"Kalkwarf HJ, Specker BL, Bianchi DC, Ranz J, Ho M (1997) The effect of calcium supplementation on bone density during lactation and after weaning. N Engl J Med 337:523\u2013528. https:\/\/doi.org\/10.1056\/nejm199708213370803","journal-title":"N Engl J Med"},{"key":"2179_CR47","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1001\/jama.1996.03540070045029","volume":"276","author":"MF Sowers","year":"1996","unstructured":"Sowers MF, Hollis BW, Shapiro B, Randolph J, Janney CA, Zhang D, Schork A, Crutchfield M, Stanczyk F, Russell-Aulet M (1996) Elevated parathyroid hormone-related peptide associated with lactation and bone density loss. JAMA 276:549\u2013554","journal-title":"JAMA"},{"key":"2179_CR48","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1172\/jci19504","volume":"112","author":"JN VanHouten","year":"2003","unstructured":"VanHouten JN, Dann P, Stewart AF, Watson CJ, Pollak M, Karaplis AC, Wysolmerski JJ (2003) Mammary-specific deletion of parathyroid hormone-related protein preserves bone mass during lactation. J Clin Invest 112:1429\u20131436. https:\/\/doi.org\/10.1172\/jci19504","journal-title":"J Clin Invest"},{"key":"2179_CR49","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1042\/cs0940405","volume":"94","author":"N Kolthoff","year":"1998","unstructured":"Kolthoff N, Eiken P, Kristensen B, Nielsen SP (1998) Bone mineral changes during pregnancy and lactation: a longitudinal cohort study. Clin Sci (Lond) 94:405\u2013412. https:\/\/doi.org\/10.1042\/cs0940405","journal-title":"Clin Sci (Lond)"},{"key":"2179_CR50","doi-asserted-by":"publisher","first-page":"2210","DOI":"10.1210\/jcem.80.7.7608281","volume":"80","author":"M Sowers","year":"1995","unstructured":"Sowers M, Eyre D, Hollis BW, Randolph JF, Shapiro B, Jannausch ML, Crutchfield M (1995) Biochemical markers of bone turnover in lactating and nonlactating postpartum women. J Clin Endocrinol Metab 80:2210\u20132216. https:\/\/doi.org\/10.1210\/jcem.80.7.7608281","journal-title":"J Clin Endocrinol Metab"},{"key":"2179_CR51","doi-asserted-by":"publisher","DOI":"10.1007\/s11657-019-0601-6","author":"S Cooke-Hubley","year":"2019","unstructured":"Cooke-Hubley S, Gao Z, Mugford G, Kaiser SM, Goltzman D, Leslie WD, Davison KS, Brown JP, Probyn L, Lentle B et al (2019) Parity and lactation are not associated with incident fragility fractures or radiographic vertebral fractures over 16\u00a0years of follow-up: Canadian multicentre osteoporosis study (CaMos). Arch Osteoporos. https:\/\/doi.org\/10.1007\/s11657-019-0601-6","journal-title":"Arch Osteoporos"},{"key":"2179_CR52","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1007\/s00198-016-3897-8","volume":"28","author":"P Hadji","year":"2017","unstructured":"Hadji P, Boekhoff J, Hahn M, Hellmeyer L, Hars O, Kyvernitakis I (2017) Pregnancy-associated osteoporosis: a case-control study. Osteoporos Int 28:1393\u20131399. https:\/\/doi.org\/10.1007\/s00198-016-3897-8","journal-title":"Osteoporos Int"},{"key":"2179_CR53","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1007\/s00198-015-3149-3","volume":"26","author":"CS Kovacs","year":"2015","unstructured":"Kovacs CS, Ralston SH (2015) Presentation and management of osteoporosis presenting in association with pregnancy or lactation. Osteoporos Int 26:2223\u20132241. https:\/\/doi.org\/10.1007\/s00198-015-3149-3","journal-title":"Osteoporos Int"},{"key":"2179_CR54","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1111\/j.1365-2265.1993.tb02398.x","volume":"39","author":"F Dunne","year":"1993","unstructured":"Dunne F, Walters B, Marshall T, Heath DA (1993) Pregnancy associated osteoporosis. Clin Endocrinol (Oxf) 39:487\u2013490. https:\/\/doi.org\/10.1111\/j.1365-2265.1993.tb02398.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2179_CR55","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1210\/jc.2013-3238","volume":"99","author":"N Campos-Obando","year":"2014","unstructured":"Campos-Obando N, Oei L, Hoefsloot LH, Kiewiet RM, Klaver CC, Simon ME, Zillikens MC (2014) Osteoporotic vertebral fractures during pregnancy: be aware of a potential underlying genetic cause. J Clin Endocrinol Metab 99:1107\u20131111. https:\/\/doi.org\/10.1210\/jc.2013-3238","journal-title":"J Clin Endocrinol Metab"},{"key":"2179_CR56","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.3750","author":"A Cohen","year":"2019","unstructured":"Cohen A, Kamanda-Kosseh M, Dempster DW, Zhou H, M\u00fcller R, Goff E, Colon I, Bucovsky M, Stubby J, Nickolas TL et al (2019) Women with pregnancy and lactation-associated osteoporosis (PLO) have low bone remodeling rates at the tissue level. J Bone Miner Res. https:\/\/doi.org\/10.1002\/jbmr.3750","journal-title":"J Bone Miner Res"},{"key":"2179_CR57","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-017-4239-1","author":"I Kyvernitakis","year":"2018","unstructured":"Kyvernitakis I, Reuter TC, Hellmeyer L, Hars O, Hadji P (2018) Subsequent fracture risk of women with pregnancy and lactation-associated osteoporosis after a median of 6\u00a0years of follow-up. Osteoporos Int. https:\/\/doi.org\/10.1007\/s00198-017-4239-1","journal-title":"Osteoporos Int"},{"key":"2179_CR58","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.tem.2016.03.006","volume":"27","author":"F Rivadeneira","year":"2016","unstructured":"Rivadeneira F, M\u00e4kitie O (2016) Osteoporosis and bone mass disorders: from gene pathways to treatments. Trends Endocrinol Metab 27:262\u2013281. https:\/\/doi.org\/10.1016\/j.tem.2016.03.006","journal-title":"Trends Endocrinol Metab"},{"key":"2179_CR59","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2249","author":"K Estrada","year":"2012","unstructured":"Estrada K, Styrkarsdottir U, Evangelou E, Hsu YH, Duncan EL, Ntzani EE, Oei L, Albagha OM, Amin N, Kemp JP et al (2012) Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture. Nat Genet. https:\/\/doi.org\/10.1038\/ng.2249","journal-title":"Nat Genet"},{"key":"2179_CR60","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1056\/NEJMra0808700","volume":"360","author":"J Hardy","year":"2009","unstructured":"Hardy J, Singleton A (2009) Genomewide association studies and human disease. N Engl J Med 360:1759\u20131768. https:\/\/doi.org\/10.1056\/NEJMra0808700","journal-title":"N Engl J Med"},{"key":"2179_CR61","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.731217","author":"M Rauner","year":"2021","unstructured":"Rauner M, Foessl I, Formosa MM, Kague E, Prijatelj V, Lopez NA, Banerjee B, Bergen D, Busse B, Calado \u00c2 et al (2021) Perspective of the GEMSTONE consortium on current and future approaches to functional validation for skeletal genetic disease using cellular. Molecular and Animal-Modeling Techniques Front Endocrinol (Lausanne). https:\/\/doi.org\/10.3389\/fendo.2021.731217","journal-title":"Molecular and Animal-Modeling Techniques Front Endocrinol (Lausanne)"},{"key":"2179_CR62","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k3225","author":"K Trajanoska","year":"2018","unstructured":"Trajanoska K, Morris JA, Oei L, Zheng HF, Evans DM, Kiel DP, Ohlsson C, Richards JB, Rivadeneira F (2018) Assessment of the genetic and clinical determinants of fracture risk: genome wide association and mendelian randomisation study. BMJ. https:\/\/doi.org\/10.1136\/bmj.k3225","journal-title":"BMJ"},{"key":"2179_CR63","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.709711","author":"MM Formosa","year":"2021","unstructured":"Formosa MM, Bergen DJM, Gregson CL, Maurizi A, K\u00e4mpe A, Garcia-Giralt N, Zhou W, Grinberg D, Ovejero Crespo D, Zillikens MC et al (2021) A Roadmap to gene discoveries and novel therapies in monogenic low and high bone mass disorders. Front Endocrinol (Lausanne). https:\/\/doi.org\/10.3389\/fendo.2021.709711","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2179_CR64","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.63132","author":"S Unger","year":"2023","unstructured":"Unger S, Ferreira CR, Mortier GR, Ali H, Bertola DR, Calder A, Cohn DH, Cormier-Daire V, Girisha KM, Hall C et al (2023) Nosology of genetic skeletal disorders: 2023 revision. Am J Med Genet A. https:\/\/doi.org\/10.1002\/ajmg.a.63132","journal-title":"Am J Med Genet A"},{"key":"2179_CR65","doi-asserted-by":"publisher","DOI":"10.1002\/jbm4.10454","author":"C Gistelinck","year":"2021","unstructured":"Gistelinck C, Weis M, Rai J, Schwarze U, Niyazov D, Song KM, Byers PH, Eyre DR (2021) Abnormal bone collagen cross-linking in osteogenesis imperfecta\/bruck syndrome caused by compound heterozygous PLOD2 mutations. JBMR Plus. https:\/\/doi.org\/10.1002\/jbm4.10454","journal-title":"JBMR Plus"},{"key":"2179_CR66","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1210\/endrev\/bnab017","volume":"43","author":"M Jovanovic","year":"2022","unstructured":"Jovanovic M, Guterman-Ram G, Marini JC (2022) Osteogenesis Imperfecta: mechanisms and signaling pathways connecting classical and rare OI types. Endocr Rev 43:61\u201390. https:\/\/doi.org\/10.1210\/endrev\/bnab017","journal-title":"Endocr Rev"},{"key":"2179_CR67","doi-asserted-by":"publisher","DOI":"10.1007\/s00441-009-0872-0","author":"JC Marini","year":"2010","unstructured":"Marini JC, Cabral WA, Barnes AM (2010) Null mutations in LEPRE1 and CRTAP cause severe recessive osteogenesis imperfecta. Cell Tissue Res. https:\/\/doi.org\/10.1007\/s00441-009-0872-0","journal-title":"Cell Tissue Res"},{"key":"2179_CR68","doi-asserted-by":"publisher","first-page":"17052","DOI":"10.1038\/nrdp.2017.52","volume":"3","author":"JC Marini","year":"2017","unstructured":"Marini JC, Forlino A, B\u00e4chinger HP, Bishop NJ, Byers PH, Paepe A, Fassier F, Fratzl-Zelman N, Kozloff KM, Krakow D et al (2017) Osteogenesis imperfecta. Nat Rev Dis Primers 3:17052. https:\/\/doi.org\/10.1038\/nrdp.2017.52","journal-title":"Nat Rev Dis Primers"},{"key":"2179_CR69","doi-asserted-by":"publisher","first-page":"R95","DOI":"10.1530\/eje-20-0299","volume":"183","author":"R Marom","year":"2020","unstructured":"Marom R, Rabenhorst BM, Morello R (2020) Osteogenesis imperfecta: an update on clinical features and therapies. Eur J Endocrinol 183:R95-r106. https:\/\/doi.org\/10.1530\/eje-20-0299","journal-title":"Eur J Endocrinol"},{"key":"2179_CR70","doi-asserted-by":"publisher","DOI":"10.1002\/humu.21647","author":"V Mart\u00ednez-Glez","year":"2012","unstructured":"Mart\u00ednez-Glez V, Valencia M, Caparr\u00f3s-Mart\u00edn JA, Aglan M, Temtamy S, Tenorio J, Pulido V, Lindert U, Rohrbach M, Eyre D et al (2012) Identification of a mutation causing deficient BMP1\/mTLD proteolytic activity in autosomal recessive osteogenesis imperfecta. Hum Mutat. https:\/\/doi.org\/10.1002\/humu.21647","journal-title":"Hum Mutat"},{"key":"2179_CR71","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/nm.3074","volume":"19","author":"R Baron","year":"2013","unstructured":"Baron R, Kneissel M (2013) WNT signaling in bone homeostasis and disease: from human mutations to treatments. Nat Med 19:179\u2013192. https:\/\/doi.org\/10.1038\/nm.3074","journal-title":"Nat Med"},{"key":"2179_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/s0092-8674(01)00571-2","author":"Y Gong","year":"2001","unstructured":"Gong Y, Slee RB, Fukai N, Rawadi G, Roman-Roman S, Reginato AM, Wang H, Cundy T, Glorieux FH, Lev D et al (2001) LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell. https:\/\/doi.org\/10.1016\/s0092-8674(01)00571-2","journal-title":"Cell"},{"key":"2179_CR73","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.ajhg.2013.02.010","volume":"92","author":"K Keupp","year":"2013","unstructured":"Keupp K, Beleggia F, Kayserili H, Barnes AM, Steiner M, Semler O, Fischer B, Yigit G, Janda CY, Becker J et al (2013) Mutations in WNT1 cause different forms of bone fragility. Am J Hum Genet 92:565\u2013574. https:\/\/doi.org\/10.1016\/j.ajhg.2013.02.010","journal-title":"Am J Hum Genet"},{"key":"2179_CR74","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1056\/NEJMoa1215458","volume":"368","author":"CM Laine","year":"2013","unstructured":"Laine CM, Joeng KS, Campeau PM, Kiviranta R, Tarkkonen K, Grover M, Lu JT, Pekkinen M, Wessman M, Heino TJ et al (2013) WNT1 mutations in early-onset osteoporosis and osteogenesis imperfecta. N Engl J Med 368:1809\u20131816. https:\/\/doi.org\/10.1056\/NEJMoa1215458","journal-title":"N Engl J Med"},{"key":"2179_CR75","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgac752","author":"J Hu","year":"2023","unstructured":"Hu J, Lin X, Gao P, Zhang Q, Zhou B, Wang O, Jiang Y, Xia W, Xing X, Li M (2023) Genotypic and phenotypic spectrum and pathogenesis of WNT1 variants in a large cohort of patients with OI\/osteoporosis. J Clin Endocrinol Metab. https:\/\/doi.org\/10.1210\/clinem\/dgac752","journal-title":"J Clin Endocrinol Metab"},{"key":"2179_CR76","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1002\/jbmr.2841","volume":"31","author":"RE M\u00e4kitie","year":"2016","unstructured":"M\u00e4kitie RE, Haanp\u00e4\u00e4 M, Valta H, Pekkinen M, Laine CM, Lehesjoki AE, Schalin-J\u00e4ntti C, M\u00e4kitie O (2016) Skeletal characteristics of WNT1 osteoporosis in children and young adults. J Bone Miner Res 31:1734\u20131742. https:\/\/doi.org\/10.1002\/jbmr.2841","journal-title":"J Bone Miner Res"},{"key":"2179_CR77","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.bone.2017.04.001","volume":"101","author":"RE M\u00e4kitie","year":"2017","unstructured":"M\u00e4kitie RE, Niinim\u00e4ki T, Nieminen MT, Schalin-J\u00e4ntti C, Niinim\u00e4ki J, M\u00e4kitie O (2017) Impaired WNT signaling and the spine-heterozygous WNT1 mutation causes severe age-related spinal pathology. Bone 101:3\u20139. https:\/\/doi.org\/10.1016\/j.bone.2017.04.001","journal-title":"Bone"},{"key":"2179_CR78","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1002\/ajmg.a.61119","volume":"179","author":"S Nampoothiri","year":"2019","unstructured":"Nampoothiri S, Guillemyn B, Elcioglu N, Jagadeesh S, Yesodharan D, Suresh B, Turan S, Symoens S, Malfait F (2019) Ptosis as a unique hallmark for autosomal recessive WNT1-associated osteogenesis imperfecta. Am J Med Genet A 179:908\u2013914. https:\/\/doi.org\/10.1002\/ajmg.a.61119","journal-title":"Am J Med Genet A"},{"key":"2179_CR79","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s00198-022-06609-2","volume":"34","author":"P Peris","year":"2023","unstructured":"Peris P, Monegal A, M\u00e4kitie RE, Gua\u00f1abens N, Gonz\u00e1lez-Roca E (2023) Osteoporosis related to WNT1 variants: a not infrequent cause of osteoporosis. Osteoporos Int 34:405\u2013411. https:\/\/doi.org\/10.1007\/s00198-022-06609-2","journal-title":"Osteoporos Int"},{"key":"2179_CR80","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1056\/NEJMoa1308223","volume":"369","author":"FS van Dijk","year":"2013","unstructured":"van Dijk FS, Zillikens MC, Micha D, Riessland M, Marcelis CL, de Die-Smulders CE, Milbradt J, Franken AA, Harsevoort AJ, Lichtenbelt KD et al (2013) PLS3 mutations in X-linked osteoporosis with fractures. N Engl J Med 369:1529\u20131536. https:\/\/doi.org\/10.1056\/NEJMoa1308223","journal-title":"N Engl J Med"},{"key":"2179_CR81","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1002\/jbmr.2355","volume":"30","author":"CM Laine","year":"2015","unstructured":"Laine CM, Wessman M, Toiviainen-Salo S, Kaunisto MA, M\u00e4yr\u00e4np\u00e4\u00e4 MK, Laine T, Pekkinen M, Kr\u00f6ger H, V\u00e4lim\u00e4ki VV, V\u00e4lim\u00e4ki MJ et al (2015) A novel splice mutation in PLS3 causes X-linked early onset low-turnover osteoporosis. J Bone Miner Res 30:510\u2013518. https:\/\/doi.org\/10.1002\/jbmr.2355","journal-title":"J Bone Miner Res"},{"key":"2179_CR82","doi-asserted-by":"publisher","first-page":"393","DOI":"10.3389\/fendo.2020.00393","volume":"11","author":"RE M\u00e4kitie","year":"2020","unstructured":"M\u00e4kitie RE, Niinim\u00e4ki T, Suo-Palosaari M, K\u00e4mpe A, Costantini A, Toiviainen-Salo S, Niinim\u00e4ki J, M\u00e4kitie O (2020) PLS3 Mutations cause severe age and sex-related spinal pathology. Front Endocrinol (Lausanne) 11:393. https:\/\/doi.org\/10.3389\/fendo.2020.00393","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2179_CR83","doi-asserted-by":"publisher","first-page":"5275","DOI":"10.1007\/s00018-021-03843-5","volume":"78","author":"L Wolff","year":"2021","unstructured":"Wolff L, Strathmann EA, M\u00fcller I, M\u00e4hlich D, Veltman C, Niehoff A, Wirth B (2021) Plastin 3 in health and disease: a matter of balance. Cell Mol Life Sci 78:5275\u20135301. https:\/\/doi.org\/10.1007\/s00018-021-03843-5","journal-title":"Cell Mol Life Sci"},{"key":"2179_CR84","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.1210\/jc.2017-00099","volume":"102","author":"K Wesseling-Perry","year":"2017","unstructured":"Wesseling-Perry K, M\u00e4kitie RE, V\u00e4lim\u00e4ki VV, Laine T, Laine CM, V\u00e4lim\u00e4ki MJ, Pereira RC, M\u00e4kitie O (2017) Osteocyte protein expression is altered in low-turnover osteoporosis caused by mutations in WNT1 and PLS3. J Clin Endocrinol Metab 102:2340\u20132348. https:\/\/doi.org\/10.1210\/jc.2017-00099","journal-title":"J Clin Endocrinol Metab"},{"key":"2179_CR85","doi-asserted-by":"publisher","first-page":"2394","DOI":"10.1002\/jbmr.3233","volume":"32","author":"AJ K\u00e4mpe","year":"2017","unstructured":"K\u00e4mpe AJ, Costantini A, Levy-Shraga Y, Zeitlin L, Roschger P, Taylan F, Lindstrand A, Paschalis EP, Gamsjaeger S, Raas-Rothschild A et al (2017) PLS3 Deletions lead to severe spinal osteoporosis and disturbed bone matrix mineralization. J Bone Miner Res 32:2394\u20132404. https:\/\/doi.org\/10.1002\/jbmr.3233","journal-title":"J Bone Miner Res"},{"key":"2179_CR86","doi-asserted-by":"publisher","first-page":"e10509","DOI":"10.1002\/jbm4.10509","volume":"5","author":"RE M\u00e4kitie","year":"2021","unstructured":"M\u00e4kitie RE, Henning P, Jiu Y, K\u00e4mpe A, Kogan K, Costantini A, V\u00e4lim\u00e4ki VV, Medina-Gomez C, Pekkinen M, Salusky IB et al (2021) An ARHGAP25 variant links aberrant Rac1 function to early-onset skeletal fragility. JBMR Plus 5:e10509. https:\/\/doi.org\/10.1002\/jbm4.10509","journal-title":"JBMR Plus"},{"key":"2179_CR87","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.126180","author":"M Pekkinen","year":"2019","unstructured":"Pekkinen M, Terhal PA, Botto LD, Henning P, M\u00e4kitie RE, Roschger P, Jain A, Kol M, Kjellberg MA, Paschalis EP et al (2019) Osteoporosis and skeletal dysplasia caused by pathogenic variants in SGMS2. JCI Insight. https:\/\/doi.org\/10.1172\/jci.insight.126180","journal-title":"JCI Insight"},{"key":"2179_CR88","doi-asserted-by":"publisher","first-page":"e10537","DOI":"10.1002\/jbm4.10537","volume":"5","author":"RE M\u00e4kitie","year":"2021","unstructured":"M\u00e4kitie RE, Blouin S, V\u00e4lim\u00e4ki VV, Pihlstr\u00f6m S, M\u00e4\u00e4tt\u00e4 K, Pekkinen M, Fratzl-Zelman N, M\u00e4kitie O, Hartmann MA (2021) Abnormal bone tissue organization and osteocyte Lacunocanalicular network in early-onset osteoporosis due to SGMS2 mutations. JBMR Plus 5:e10537. https:\/\/doi.org\/10.1002\/jbm4.10537","journal-title":"JBMR Plus"},{"key":"2179_CR89","doi-asserted-by":"publisher","first-page":"101121","DOI":"10.1016\/j.bonr.2021.101121","volume":"15","author":"S Basalom","year":"2021","unstructured":"Basalom S, Fiscaletti M, Miranda V, Huber C, Couture G, Drouin R, Monceau \u00c9, Wavrant S, Dub\u00e9 J, M\u00e4kitie O et al (2021) Calvarial doughnut lesions with bone fragility in a French-Canadian family; case report and review of the literature. Bone Rep 15:101121. https:\/\/doi.org\/10.1016\/j.bonr.2021.101121","journal-title":"Bone Rep"},{"key":"2179_CR90","doi-asserted-by":"publisher","first-page":"115261","DOI":"10.1016\/j.bone.2020.115261","volume":"134","author":"ME Robinson","year":"2020","unstructured":"Robinson ME, Bardai G, Veilleux LN, Glorieux FH, Rauch F (2020) Musculoskeletal phenotype in two unrelated individuals with a recurrent nonsense variant in SGMS2. Bone 134:115261. https:\/\/doi.org\/10.1016\/j.bone.2020.115261","journal-title":"Bone"},{"key":"2179_CR91","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/jbm4.10020","volume":"2","author":"C Collet","year":"2018","unstructured":"Collet C, Ostertag A, Ricquebourg M, Delecourt M, Tueur G, Isidor B, Guillot P, Schaefer E, Javier RM, Funck-Brentano T et al (2018) Primary osteoporosis in young adults: genetic basis and identification of novel variants in causal genes. JBMR Plus 2:12\u201321. https:\/\/doi.org\/10.1002\/jbm4.10020","journal-title":"JBMR Plus"},{"key":"2179_CR92","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/j.bone.2005.06.017","volume":"37","author":"SL Ferrari","year":"2005","unstructured":"Ferrari SL, Deutsch S, Baudoin C, Cohen-Solal M, Ostertag A, Antonarakis SE, Rizzoli R, de Vernejoul MC (2005) LRP5 gene polymorphisms and idiopathic osteoporosis in men. Bone 37:770\u2013775. https:\/\/doi.org\/10.1016\/j.bone.2005.06.017","journal-title":"Bone"},{"key":"2179_CR93","doi-asserted-by":"publisher","first-page":"3095","DOI":"10.1210\/jc.2011-1387","volume":"96","author":"A Cohen","year":"2011","unstructured":"Cohen A, Dempster DW, Recker RR, Stein EM, Lappe JM, Zhou H, Wirth AJ, van Lenthe GH, Kohler T, Zwahlen A et al (2011) Abnormal bone microarchitecture and evidence of osteoblast dysfunction in premenopausal women with idiopathic osteoporosis. J Clin Endocrinol Metab 96:3095\u20133105. https:\/\/doi.org\/10.1210\/jc.2011-1387","journal-title":"J Clin Endocrinol Metab"},{"key":"2179_CR94","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1359\/jbmr.050101","volume":"20","author":"H Hartikka","year":"2005","unstructured":"Hartikka H, M\u00e4kitie O, M\u00e4nnikk\u00f6 M, Doria AS, Daneman A, Cole WG, Ala-Kokko L, Sochett EB (2005) Heterozygous mutations in the LDL receptor-related protein 5 (LRP5) gene are associated with primary osteoporosis in children. J Bone Miner Res 20:783\u2013789. https:\/\/doi.org\/10.1359\/jbmr.050101","journal-title":"J Bone Miner Res"},{"key":"2179_CR95","doi-asserted-by":"publisher","first-page":"101176","DOI":"10.1016\/j.bonr.2022.101176","volume":"16","author":"C Rouleau","year":"2022","unstructured":"Rouleau C, Malorie M, Collet C, Porquet-Bordes V, Gennero I, Eddiry S, Laroche M, Salles JP, Couture G, Edouard T (2022) Diagnostic yield of bone fragility gene panel sequencing in children and young adults referred for idiopathic primary osteoporosis at a single regional reference centre. Bone Rep 16:101176. https:\/\/doi.org\/10.1016\/j.bonr.2022.101176","journal-title":"Bone Rep"},{"key":"2179_CR96","doi-asserted-by":"publisher","unstructured":"Peris P, Gua\u00f1abens N, Mart\u00ednez de Osaba MJ, Monegal A, Alvarez L, Pons F, Ros I, Cerd\u00e1 D and Mu\u00f1oz-G\u00f3mez J, (2002) Clinical characteristics and etiologic factors of premenopausal osteoporosis in a group of Spanish women Semin Arthritis Rheum 32:64-70. https:\/\/doi.org\/10.1053\/sarh.2002.33725","DOI":"10.1053\/sarh.2002.33725"},{"key":"2179_CR97","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/8756-3282(94)90280-1","volume":"15","author":"S Khosla","year":"1994","unstructured":"Khosla S, Lufkin EG, Hodgson SF, Fitzpatrick LA, Melton LJ 3rd (1994) Epidemiology and clinical features of osteoporosis in young individuals. Bone 15:551\u2013555. https:\/\/doi.org\/10.1016\/8756-3282(94)90280-1","journal-title":"Bone"},{"key":"2179_CR98","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.35278","author":"CM Laine","year":"2012","unstructured":"Laine CM, Koltin D, Susic M, Varley TL, Daneman A, Moineddin R, Cole WG, M\u00e4kitie O, Sochett E (2012) Primary osteoporosis without features of OI in children and adolescents: clinical and genetic characteristics. Am J Med Gene A. https:\/\/doi.org\/10.1002\/ajmg.a.35278","journal-title":"Am J Med Gene A"},{"key":"2179_CR99","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.720728","author":"I Foessl","year":"2021","unstructured":"Foessl I, Bassett JHD, Bj\u00f8rnerem \u00c5, Busse B, Calado \u00c2, Chavassieux P, Christou M, Douni E, Fiedler IAK, Fonseca JE et al (2021) Bone phenotyping approaches in human, Mice and Zebrafish - Expert Overview of the EU Cost Action GEMSTONE (\u201cGenomics of musculoskeletal traits translational network\u201d). Front Endocrinol (Lausanne). https:\/\/doi.org\/10.3389\/fendo.2021.720728","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2179_CR100","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1007\/s00198-004-1716-0","volume":"16","author":"MR Rubin","year":"2005","unstructured":"Rubin MR, Schussheim DH, Kulak CA, Kurland ES, Rosen CJ, Bilezikian JP, Shane E (2005) Idiopathic osteoporosis in premenopausal women. Osteoporos Int 16:526\u2013533. https:\/\/doi.org\/10.1007\/s00198-004-1716-0","journal-title":"Osteoporos Int"},{"key":"2179_CR101","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2022.116641","author":"MS Rand","year":"2023","unstructured":"Rand MS, Diemar SS, M\u00f8llehave LT, Heidemann M, Thuesen BH, Petersen JH, Johannesen J, Schou AJ, Wedderkopp N, M\u00f8lgaard C et al (2023) Z-scores of bone turnover markers calculated from new established sex- and age-specific reference curves are associated to future change in BMD in children and adolescents. Bone. https:\/\/doi.org\/10.1016\/j.bone.2022.116641","journal-title":"Bone"},{"key":"2179_CR102","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1210\/endrev\/bnac031","volume":"44","author":"M Schini","year":"2023","unstructured":"Schini M, Vilaca T, Gossiel F, Salam S, Eastell R (2023) Bone turnover markers: basic biology to clinical applications. Endocr Rev 44:417\u2013473. https:\/\/doi.org\/10.1210\/endrev\/bnac031","journal-title":"Endocr Rev"},{"key":"2179_CR103","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/s41576-019-0180-9","volume":"21","author":"SS Ho","year":"2020","unstructured":"Ho SS, Urban AE, Mills RE (2020) Structural variation in the sequencing era. Nat Rev Genet 21:171\u2013189. https:\/\/doi.org\/10.1038\/s41576-019-0180-9","journal-title":"Nat Rev Genet"},{"key":"2179_CR104","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1097\/mcd.0000000000000442","volume":"32","author":"LJ Apperley","year":"2023","unstructured":"Apperley LJ, Albaba S, Dharmaraj P, Balasubramanian M (2023) PLS3 whole gene deletion as a cause of X-linked osteoporosis: clinical report with review of published PLS3 literature. Clin Dysmorphol 32:43\u201347. https:\/\/doi.org\/10.1097\/mcd.0000000000000442","journal-title":"Clin Dysmorphol"},{"key":"2179_CR105","doi-asserted-by":"publisher","first-page":"380","DOI":"10.3389\/fendo.2018.00380","volume":"9","author":"A Costantini","year":"2018","unstructured":"Costantini A, Skarp S, K\u00e4mpe A, M\u00e4kitie RE, Pettersson M, M\u00e4nnikk\u00f6 M, Jiao H, Taylan F, Lindstrand A, M\u00e4kitie O (2018) Rare copy number variants in array-based comparative genomic hybridization in early-onset skeletal fragility front. Endocrinol (Lausanne) 9:380. https:\/\/doi.org\/10.3389\/fendo.2018.00380","journal-title":"Endocrinol (Lausanne)"},{"key":"2179_CR106","doi-asserted-by":"publisher","first-page":"2691","DOI":"10.1007\/s00198-017-4094-0","volume":"28","author":"F Lv","year":"2017","unstructured":"Lv F, Ma M, Liu W, Xu X, Song Y, Li L, Jiang Y, Wang O, Xia W, Xing X et al (2017) A novel large fragment deletion in PLS3 causes rare X-linked early-onset osteoporosis and response to zoledronic acid. Osteoporos Int 28:2691\u20132700. https:\/\/doi.org\/10.1007\/s00198-017-4094-0","journal-title":"Osteoporos Int"},{"key":"2179_CR107","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1002\/jbmr.1818","volume":"28","author":"R Lindsay","year":"2013","unstructured":"Lindsay R, Zhou H, Cosman F, Nieves J, Dempster D (2013) Double and quadruple tetracycline labeling of bone: impact of the label itself. J Bone Miner Res 28:222\u2013223. https:\/\/doi.org\/10.1002\/jbmr.1818","journal-title":"J Bone Miner Res"},{"key":"2179_CR108","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-005-1132-7","author":"PH Kann","year":"2006","unstructured":"Kann PH, Pf\u00fctzner A, Delling G, Schulz G, Meyer S (2006) Transiliac bone biopsy in osteoporosis: frequency, indications, consequences and complications. An evaluation of 99 consecutive cases over a period of 14 years. Clin Rheumatol. https:\/\/doi.org\/10.1007\/s10067-005-1132-7","journal-title":"Clin Rheumatol"},{"key":"2179_CR109","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/s8756-3282(99)00257-4","volume":"26","author":"FH Glorieux","year":"2000","unstructured":"Glorieux FH, Travers R, Taylor A, Bowen JR, Rauch F, Norman M, Parfitt AM (2000) Normative data for iliac bone histomorphometry in growing children. Bone 26:103\u2013109. https:\/\/doi.org\/10.1016\/s8756-3282(99)00257-4","journal-title":"Bone"},{"key":"2179_CR110","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2019.115102","author":"H Razi","year":"2020","unstructured":"Razi H, Predan J, Fischer FD, Kolednik O, Fratzl P (2020) Damage tolerance of lamellar bone. Bone. https:\/\/doi.org\/10.1016\/j.bone.2019.115102","journal-title":"Bone"},{"key":"2179_CR111","doi-asserted-by":"publisher","DOI":"10.1016\/j.bonr.2020.100734","author":"F Shapiro","year":"2021","unstructured":"Shapiro F, Maguire K, Swami S, Zhu H, Flynn E, Wang J, Wu JY (2021) Histopathology of Osteogenesis imperfecta bone. Supramolecular assessment of cells and matrices in the context of woven and lamellar bone formation using light, polarization and ultrastructural microscopy. Bone Rep. https:\/\/doi.org\/10.1016\/j.bonr.2020.100734","journal-title":"Bone Rep"},{"key":"2179_CR112","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1017\/s0007114510000437","volume":"104","author":"MZ Islam","year":"2010","unstructured":"Islam MZ, Shamim AA, Viljakainen HT, Akhtaruzzaman M, Jehan AH, Khan HU, Al-Arif FA, Lamberg-Allardt C (2010) Effect of vitamin D, calcium and multiple micronutrient supplementation on vitamin D and bone status in Bangladeshi premenopausal garment factory workers with hypovitaminosis D: a double-blinded, randomised, placebo-controlled 1-year intervention. Br J Nutr 104:241\u2013247. https:\/\/doi.org\/10.1017\/s0007114510000437","journal-title":"Br J Nutr"},{"key":"2179_CR113","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1007\/s10067-006-0405-0","volume":"26","author":"P Peris","year":"2007","unstructured":"Peris P, Monegal A, Mart\u00ednez MA, Moll C, Pons F, Gua\u00f1abens N (2007) Bone mineral density evolution in young premenopausal women with idiopathic osteoporosis. Clin Rheumatol 26:958\u2013961. https:\/\/doi.org\/10.1007\/s10067-006-0405-0","journal-title":"Clin Rheumatol"},{"key":"2179_CR114","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.1359\/jbmr.050709","volume":"20","author":"M Lorentzon","year":"2005","unstructured":"Lorentzon M, Mellstr\u00f6m D, Ohlsson C (2005) Association of amount of physical activity with cortical bone size and trabecular volumetric BMD in young adult men: the GOOD study. J Bone Miner Res 20:1936\u20131943. https:\/\/doi.org\/10.1359\/jbmr.050709","journal-title":"J Bone Miner Res"},{"key":"2179_CR115","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s11914-014-0248-6","volume":"13","author":"K Zhu","year":"2015","unstructured":"Zhu K, Prince RL (2015) Lifestyle and osteoporosis. Curr Osteoporos Rep 13:52\u201359. https:\/\/doi.org\/10.1007\/s11914-014-0248-6","journal-title":"Curr Osteoporos Rep"},{"key":"2179_CR116","doi-asserted-by":"publisher","first-page":"3903","DOI":"10.1210\/jc.2003-031885","volume":"89","author":"KK Miller","year":"2004","unstructured":"Miller KK, Grieco KA, Mulder J, Grinspoon S, Mickley D, Yehezkel R, Herzog DB, Klibanski A (2004) Effects of risedronate on bone density in anorexia nervosa. J Clin Endocrinol Metab 89:3903\u20133906. https:\/\/doi.org\/10.1210\/jc.2003-031885","journal-title":"J Clin Endocrinol Metab"},{"key":"2179_CR117","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/sj.bmt.1705196","volume":"37","author":"L Tauchmanov\u00e0","year":"2006","unstructured":"Tauchmanov\u00e0 L, De Simone G, Musella T, Orio F, Ricci P, Nappi C, Lombardi G, Colao A, Rotoli B, Selleri C (2006) Effects of various antireabsorptive treatments on bone mineral density in hypogonadal young women after allogeneic stem cell transplantation. Bone Marrow Transplant 37:81\u201388. https:\/\/doi.org\/10.1038\/sj.bmt.1705196","journal-title":"Bone Marrow Transplant"},{"key":"2179_CR118","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1378\/chest.08-0608","volume":"134","author":"A Papaioannou","year":"2008","unstructured":"Papaioannou A, Kennedy CC, Freitag A, Ioannidis G, O\u2019Neill J, Webber C, Pui M, Berthiaume Y, Rabin HR, Paterson N et al (2008) Alendronate once weekly for the prevention and treatment of bone loss in Canadian adult cystic fibrosis patients (CFOS trial). Chest 134:794\u2013800. https:\/\/doi.org\/10.1378\/chest.08-0608","journal-title":"Chest"},{"key":"2179_CR119","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2008.03434.x","author":"I Chapman","year":"2009","unstructured":"Chapman I, Greville H, Ebeling PR, King SJ, Kotsimbos T, Nugent P, Player R, Topliss DJ, Warner J, Wilson JW (2009) Intravenous zoledronate improves bone density in adults with cystic fibrosis (CF). Clin Endocrinol (Oxf). https:\/\/doi.org\/10.1111\/j.1365-2265.2008.03434.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2179_CR120","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1196\/annals.1346.055","volume":"1068","author":"M Pazianas","year":"2006","unstructured":"Pazianas M, Rhim AD, Weinberg AM, Su C, Lichtenstein GR (2006) The effect of anti-TNF-alpha therapy on spinal bone mineral density in patients with Crohn\u2019s disease. Ann N Y Acad Sci 1068:543\u2013556. https:\/\/doi.org\/10.1196\/annals.1346.055","journal-title":"Ann N Y Acad Sci"},{"key":"2179_CR121","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.bone.2010.10.173","volume":"48","author":"R Haidar","year":"2011","unstructured":"Haidar R, Musallam KM, Taher AT (2011) Bone disease and skeletal complications in patients with \u03b2 thalassemia major. Bone 48:425\u2013432. https:\/\/doi.org\/10.1016\/j.bone.2010.10.173","journal-title":"Bone"},{"key":"2179_CR122","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1002\/jbmr.4197","volume":"36","author":"J St\u00fcrznickel","year":"2021","unstructured":"St\u00fcrznickel J, Rolvien T, Delsmann A, Butscheidt S, Barvencik F, Mundlos S, Schinke T, Kornak U, Amling M, Oheim R (2021) Clinical phenotype and relevance of LRP5 and LRP6 variants in patients with early-onset osteoporosis (EOOP). J Bone Miner Res 36:271\u2013282. https:\/\/doi.org\/10.1002\/jbmr.4197","journal-title":"J Bone Miner Res"},{"key":"2179_CR123","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1210\/jc.2016-2423","volume":"102","author":"VV V\u00e4lim\u00e4ki","year":"2017","unstructured":"V\u00e4lim\u00e4ki VV, M\u00e4kitie O, Pereira R, Laine C, Wesseling-Perry K, M\u00e4\u00e4tt\u00e4 J, Kirjavainen M, Viljakainen H, V\u00e4lim\u00e4ki MJ (2017) Teriparatide treatment in patients With WNT1 or PLS3 mutation-related early-onset osteoporosis: a pilot study. J Clin Endocrinol Metab 102:535\u2013544. https:\/\/doi.org\/10.1210\/jc.2016-2423","journal-title":"J Clin Endocrinol Metab"},{"key":"2179_CR124","doi-asserted-by":"crossref","unstructured":"Kruk M, Ralston SH and Albagha OM (2009) LRP5 Polymorphisms and response to risedronate treatment in osteoporotic men Calcif Tissue Int 84:171\u2013179.","DOI":"10.1007\/s00223-008-9207-5"},{"key":"2179_CR125","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1056\/NEJMoa1607948","volume":"375","author":"F Cosman","year":"2016","unstructured":"Cosman F, Crittenden DB, Adachi JD, Binkley N, Czerwinski E, Ferrari S, Hofbauer LC, Lau E, Lewiecki EM, Miyauchi A et al (2016) Romosozumab treatment in postmenopausal women with osteoporosis. N Engl J Med 375:1532\u20131543. https:\/\/doi.org\/10.1056\/NEJMoa1607948","journal-title":"N Engl J Med"},{"key":"2179_CR126","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-020-05701-9","author":"N Binkley","year":"2021","unstructured":"Binkley N, Orwoll E, Chapurlat R, Langdahl BL, Scott BB, Giezek H, Santora AC (2021) Randomized, controlled trial to assess the safety and efficacy of odanacatib in the treatment of men with osteoporosis. Osteoporos Int. https:\/\/doi.org\/10.1007\/s00198-020-05701-9","journal-title":"Osteoporos Int"},{"key":"2179_CR127","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1056\/NEJMoa1714641","volume":"378","author":"TO Carpenter","year":"2018","unstructured":"Carpenter TO, Whyte MP, Imel EA, Boot AM, H\u00f6gler W, Linglart A, Padidela R, Van\u2019t Hoff W, Mao M, Chen CY et al (2018) Burosumab therapy in children with X-linked hypophosphatemia. N Engl J Med 378:1987\u20131998. https:\/\/doi.org\/10.1056\/NEJMoa1714641","journal-title":"N Engl J Med"},{"key":"2179_CR128","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1056\/NEJMoa0809493","volume":"361","author":"SR Cummings","year":"2009","unstructured":"Cummings SR, San Martin J, McClung MR, Siris ES, Eastell R, Reid IR, Delmas P, Zoog HB, Austin M, Wang A et al (2009) Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med 361:756\u2013765. https:\/\/doi.org\/10.1056\/NEJMoa0809493","journal-title":"N Engl J Med"},{"key":"2179_CR129","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1056\/NEJMoa1106173","volume":"366","author":"MP Whyte","year":"2012","unstructured":"Whyte MP, Greenberg CR, Salman NJ, Bober MB, McAlister WH, Wenkert D, Van Sickle BJ, Simmons JH, Edgar TS, Bauer ML et al (2012) Enzyme-replacement therapy in life-threatening hypophosphatasia. N Engl J Med 366:904\u2013913. https:\/\/doi.org\/10.1056\/NEJMoa1106173","journal-title":"N Engl J Med"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-023-02179-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-023-02179-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-023-02179-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T16:35:48Z","timestamp":1708014948000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-023-02179-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,5]]},"references-count":129,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,2]]}},"alternative-id":["2179"],"URL":"https:\/\/doi.org\/10.1007\/s40618-023-02179-0","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,5]]},"assertion":[{"value":"5 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"No informed consent required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}